Podcast 28 Jun 2024
Priovant – finding treatments for autoimmune diseases
Listen to our conversation with Priovant Therapeutics, developing therapies for autoimmune diseases with high morbidity.
About
After I graduated with a master’s degree in European Law from the
University of Tours, I decided to study journalism at the All Media
Journalism Institute of Lille. During this time, I discovered the healthcare
innovation ecosystem and enjoyed writing about it for Eurasanté, a French
healthcare cluster. I am interested in different subjects other than
healthcare and biotechnology: cinema, sports, photography… Journalism
had always been at the back of my mind, and I am delighted to write for
Labiotech as a junior reporter. When I am not working you might find me on the tennis court or picking up the next piece of furniture I will renovate.
Articles by Jules Adam
In Depth 26 Jun 2024
Biotech megadeals: Exploring the surge in $100M+ deals
Biotech and healtcare contributed to more than one out of three megadeals in 2024, find out the reasons behind it.
Best in Biotech 25 Jun 2024
Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024
Delve into the biotech landscape of the state of Georgia and discover seven companies leading the charge in the industry.
Best in Biotech 20 Jun 2024
CRISPR technology’s next wave: Eight companies to watch in 2024
Driven by CASGEVY’s success, the CRISPR field is experiencing substantial growth with a new wave of companies.
Expert Advice 13 Jun 2024
From AI to telemedicine: Transforming clinical trial recruitment in 2024
Delve into the evolution of clinical trial recruitment in the recent years, with decentralized and virtual trials gaining traction.
Best in Biotech 13 Jun 2024
Eight companies tackling cancer with allogeneic cell therapy in 2024
Unlike autologous cell therapy, where the patient’s own cells are used, allogeneic cell therapy companies leverage donor cells, which can come from various sources such as bone marrow or umbilical cord blood. In allogeneic cell therapy, healthy donor cells are harvested, processed, and then infused into the patient. These donor cells can differentiate into various […]
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 6 Jun 2024
Eight biotech companies advancing the field of siRNA
Explore the growing sector of siRNA and discover eight biotech companies spearheading this innovative field.
Best in Biotech 4 Jun 2024
Ohio’s finest: Eight biotech companies leading the way
While Ohio has a strong emphasis on manufacturing, the state is home to several innovative biotech companies.
Podcast 31 May 2024
Can cell therapy tackle hearing loss
Hearing loss is a growing global challenge. UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss.
Best in Biotech 30 May 2024
Stem cell therapy’s avant-garde: Eight companies leading the way
Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field.
More News! 27 May 2024
New report shows that Swiss biotech capital investment surged last year
With a record revenue of $8 billion in 2023, Swiss biotech appears robust in 2024. Delve into the findings of the Swiss Biotech Report 2024.
Expert Advice 24 May 2024
Mission statement, the key to success for biotech companies
Mission statement, purpose and vision are essential to the success of a biotech. Delve into the stategies to build on company culture.
ADVERTISEMENT
